BBS-Bioactive Bone Substitutes Oyj (BONEH) — Cash Flow Quality Index

Latest as of June 2018: -1.13x

BBS-Bioactive Bone Substitutes Oyj (BONEH) has a Cash Flow Quality Index of -1.13x as of June 2018. Operating cash flow of €-1.15K is below net income of €1.02K, suggesting accrual-heavy earnings not yet converted to cash. Explore BBS-Bioactive Bone Substitutes Oyj cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.13x
Operating CF / Net Income

Operating Cash Flow

€-1.15K
EUR

Net Income

€1.02K
EUR

Data as of

Jun 2018
Most recent filing

BBS-Bioactive Bone Substitutes Oyj Cash Flow Quality Index (2018–2018)

Historical Cash Flow Quality Index for BBS-Bioactive Bone Substitutes Oyj across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See how leveraged is BBS-Bioactive Bone Substitutes Oyj's balance sheet to measure how much of total assets are equity-financed.

Annual Cash Flow Quality Index for BBS-Bioactive Bone Substitutes Oyj (2018–2018)

Year-by-year earnings quality comparison for BBS-Bioactive Bone Substitutes Oyj. For the full cash flow conversion analysis, see BBS-Bioactive Bone Substitutes Oyj cash flow conversion.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2018 -4.48x €-1.70 Million €380.00K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.